Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

[Licensing procedures for human vaccines in Germany and Europe and the WHO prequalification program].

Grabski E, Hildt E, Wagner R.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Nov 27. doi: 10.1007/s00103-019-03059-w. [Epub ahead of print] Review. German.

PMID:
31776598
2.

Proline-based allosteric inhibitors of Zika and Dengue virus NS2B/NS3 proteases.

Millies B, von Hammerstein F, Gellert A, Hammerschmidt S, Barthels F, Göppel U, Immerheiser M, Elgner F, Jung N, Basic M, Kersten C, Kiefer W, Bodem J, Hildt E, Windbergs M, Hellmich UA, Schirmeister T.

J Med Chem. 2019 Nov 26. doi: 10.1021/acs.jmedchem.9b01697. [Epub ahead of print]

PMID:
31769670
3.

A synthetic derivative of houttuynoid B prevents cell entry of Zika virus.

Basic M, Elgner F, Bender D, Sabino C, Herrlein ML, Roth H, Glitscher M, Fath A, Kerl T, Schmalz HG, Hildt E.

Antiviral Res. 2019 Dec;172:104644. doi: 10.1016/j.antiviral.2019.104644. Epub 2019 Nov 4.

PMID:
31697958
4.

Editorial: HBV-the naked truth? Authors' reply.

Jiang B, Peiffer KH, Hildt E.

Aliment Pharmacol Ther. 2019 Oct;50(8):964-965. doi: 10.1111/apt.15452. No abstract available.

PMID:
31591771
5.

Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis.

Bender D, Hildt E.

Int J Mol Sci. 2019 Sep 19;20(18). pii: E4659. doi: 10.3390/ijms20184659. Review.

6.

ZIKV Envelope Domain-Specific Antibodies: Production, Purification and Characterization.

Akhras S, Herrlein ML, Elgner F, Holzhauser T, Hildt E.

Viruses. 2019 Aug 13;11(8). pii: E748. doi: 10.3390/v11080748.

7.

Multifunctionality of structural proteins in the enterovirus life cycle.

Wen X, Sun D, Guo J, Elgner F, Wang M, Hildt E, Cheng A.

Future Microbiol. 2019 Sep;14:1147-1157. doi: 10.2217/fmb-2019-0127. Epub 2019 Aug 1.

PMID:
31368347
8.

Formation of semi-enveloped particles as a unique feature of a hepatitis B virus PreS1 deletion mutant.

Jiang B, Wu Q, Kuhnhenn L, Akhras S, Spengler C, Boller K, Peiffer KH, Hildt E.

Aliment Pharmacol Ther. 2019 Oct;50(8):940-954. doi: 10.1111/apt.15381. Epub 2019 Jun 25.

PMID:
31240738
9.

Bafilomycin A1 and U18666A Efficiently Impair ZIKV Infection.

Sabino C, Basic M, Bender D, Elgner F, Himmelsbach K, Hildt E.

Viruses. 2019 Jun 6;11(6). pii: E524. doi: 10.3390/v11060524.

10.

[Rethinking vaccination: starting points and perspectives of a modern vaccination strategy].

Hildt E, Ludwig MS, Kuhn J.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):383-385. doi: 10.1007/s00103-019-02925-x. German. No abstract available.

PMID:
30847520
11.

[Composition and mode of action of adjuvants in licensed viral vaccines].

Wagner R, Hildt E.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):462-471. doi: 10.1007/s00103-019-02921-1. Review. German.

PMID:
30830257
12.

Relevance of Rab Proteins for the Life Cycle of Hepatitis C Virus.

Elgner F, Hildt E, Bender D.

Front Cell Dev Biol. 2018 Dec 4;6:166. doi: 10.3389/fcell.2018.00166. eCollection 2018. Review.

13.

Life cycle and morphogenesis of the hepatitis E virus.

Himmelsbach K, Bender D, Hildt E.

Emerg Microbes Infect. 2018 Nov 29;7(1):196. doi: 10.1038/s41426-018-0198-7. Review.

14.

Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol.

Glitscher M, Himmelsbach K, Woytinek K, Johne R, Reuter A, Spiric J, Schwaben L, Grünweller A, Hildt E.

Viruses. 2018 Jun 2;10(6). pii: E301. doi: 10.3390/v10060301.

15.

Macrophage-Derived Extracellular Vesicles Induce Long-Lasting Immunity Against Hepatitis C Virus Which Is Blunted by Polyunsaturated Fatty Acids.

Cai C, Koch B, Morikawa K, Suda G, Sakamoto N, Rueschenbaum S, Akhras S, Dietz J, Hildt E, Zeuzem S, Welsch C, Lange CM.

Front Immunol. 2018 Apr 12;9:723. doi: 10.3389/fimmu.2018.00723. eCollection 2018.

16.

Inhibition of Zika Virus Replication by Silvestrol.

Elgner F, Sabino C, Basic M, Ploen D, Grünweller A, Hildt E.

Viruses. 2018 Mar 27;10(4). pii: E149. doi: 10.3390/v10040149.

17.

Divergent preS Sequences in Virion-Associated Hepatitis B Virus Genomes and Subviral HBV Surface Antigen Particles From HBV e Antigen-Negative Patients.

Peiffer KH, Kuhnhenn L, Jiang B, Mondorf A, Vermehren J, Knop V, Susser S, Walter D, Dietz J, Carra G, Finkelmeier F, Zeuzem S, Sarrazin C, Hildt E.

J Infect Dis. 2018 Jun 5;218(1):114-123. doi: 10.1093/infdis/jiy119.

PMID:
29528436
18.

Identification of various cell culture models for the study of Zika virus.

Himmelsbach K, Hildt E.

World J Virol. 2018 Feb 12;7(1):10-20. doi: 10.5501/wjv.v7.i1.10.

19.

Cell-permeable capsids as universal antigen carrier for the induction of an antigen-specific CD8+ T-cell response.

Akhras S, Toda M, Boller K, Himmelsbach K, Elgner F, Biehl M, Scheurer S, Gratz M, Vieths S, Hildt E.

Sci Rep. 2017 Aug 29;7(1):9630. doi: 10.1038/s41598-017-08787-0.

20.

HCV-induced oxidative stress by inhibition of Nrf2 triggers autophagy and favors release of viral particles.

Medvedev R, Ploen D, Spengler C, Elgner F, Ren H, Bunten S, Hildt E.

Free Radic Biol Med. 2017 Sep;110:300-315. doi: 10.1016/j.freeradbiomed.2017.06.021. Epub 2017 Jun 30.

PMID:
28673615

Supplemental Content

Loading ...
Support Center